<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03889353</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0417</org_study_id>
    <nct_id>NCT03889353</nct_id>
  </id_info>
  <brief_title>Brain Computer Interface and Virtual Reality (BCI-VR) for Pain Treatment</brief_title>
  <acronym>GHOST</acronym>
  <official_title>Is Mental Motor Imagery Training Using &quot;GHOST&quot;, a Novel BCI-VR Feedback System (Brain Computer Interface and Virtual Reality) Efficient and Safe for Pain Relief in Phantom Limb Pain After Upper Limb Amputation or Brachial Plexus Lesion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation Apicil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot Interventional study with minimal risks and constraints, prospective, monocentric.&#xD;
      Safety and Efficacity evaluation of a Novel Medical Device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Upper limb's phantom pain, due to amputation or to injury of the brachial plexus are possibly&#xD;
      due to maladaptive CNS (central nervous system facility) plasticity and thus could be&#xD;
      decreased by retraining the sensorimotor cortex using Mental Motor Imaging guided through a&#xD;
      novel BCI-RV feedback system : &quot;Ghost&quot;. The aim of this study is to evaluate safety and&#xD;
      efficacy of this BCI pain treatment developed by our team.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 9, 2019</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of BCI intervention on mean daily pain</measure>
    <time_frame>month 6</time_frame>
    <description>Determination by curve fitting technique (regression analysis) of the peak effect and calculation of the rate of improvement: success if&gt; 30%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the effectiveness of the BCI intervention on paroxysmal pains</measure>
    <time_frame>60 days from day -30 to day + 30 , once a week from Month 1 to month 6</time_frame>
    <description>duration of the paroxysmal pains</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the effectiveness of the BCI intervention on paroxysmal pains</measure>
    <time_frame>60 days from day -30 to day + 30 , once a week from Month 1 to month 6</time_frame>
    <description>the intensity of paroxysmal pains This scale measures the intensity of paroxysmal pain. It is a self-assessment. Scores measured with Visual Analog Score.&#xD;
The scale is graded from 0 (no pain) to 10 (most intense pain the patient can imagine).&#xD;
The value 10 (maximum) is the worst result. There is no combination of sub-ranges to compute the score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the effectiveness of the BCI intervention on paroxysmal pains</measure>
    <time_frame>60 days from day -30 to day + 30 , once a week from Month 1 to month 6</time_frame>
    <description>the frequency of paroxysmal pains</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the effect of the intervention on quality of life: SF36</measure>
    <time_frame>Day 1, 12, 90, 180</time_frame>
    <description>SF36 Questionnaire quality of life For each question, an algorithm allows the calculation of scores to obtain a number between 0 (zero quality - worse outcome) and 100 (maximum quality).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the effect of the intervention on anxiety and depression</measure>
    <time_frame>Day 1, 12, 90, 180</time_frame>
    <description>HAD questionnaire : Hospital Anxiety and Depression scale It includes 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), resulting in two scores (maximum score of each score = 21).&#xD;
To detect anxious and depressive symptoms, the following interpretation can be proposed for each of the scores (A and D):&#xD;
7 or less: lack of symptomatology&#xD;
8 to 10: doubtful symptomatology - 11 and more: definite symptomatology.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evaluating cortical plasticity</measure>
    <time_frame>Day 1, 12, 30</time_frame>
    <description>MRI analysis the physiopathological mechanisms governing phantom pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evaluating cortical plasticity</measure>
    <time_frame>Day 1, 12, 30</time_frame>
    <description>EEG analysis the physiopathological mechanisms governing phantom pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the performance of subjects to control the neurofeedback system</measure>
    <time_frame>Day 1, 12, 30</time_frame>
    <description>Motor Imagery Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>BCI sessions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>up to 3 test sessions (Day-30) to eliminate BCI illiteracy, then 10 rehabilitation sessions of 90 minutes (Day 1-Day 5 and Day 8-Day 12) - Session content : Guided training - Control of an avatar (VR, first person view) of the affected limb by motor mental imagery decoded by a brain computer interface.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BCI sessions</intervention_name>
    <description>up to 3 test sessions (D-30) to eliminate BCI illiteracy, then 10 rehabilitation sessions of 90 minutes (D1-D5 and D8-D12) - Session content : Guided training - Control of an avatar (VR, first person view) of the affected limb by motor mental imagery decoded by a brain computer interface.</description>
    <arm_group_label>BCI sessions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Neuropathic pain / Phantom limb pain&#xD;
&#xD;
          -  Mean pain score &gt;3 centimeter&#xD;
&#xD;
          -  Permanent pain&#xD;
&#xD;
          -  If Plexus Brachial injury : &gt; 6 month&#xD;
&#xD;
          -  If Amputation : at least at wrist level&#xD;
&#xD;
          -  Motor and Sensory deficit : complete or incomplete&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Public Health Insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  MRI contraindication&#xD;
&#xD;
          -  Subject included in another interventional study&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Majors under guardianship or curatorship or safeguard of justice&#xD;
&#xD;
          -  History of associated head injury or any other neurological pathology altering the&#xD;
             sensorimotor cerebral system or cognitive abilities and higher functions.&#xD;
&#xD;
          -  Presence of other lesions of the peripheral nervous system that may induce associated&#xD;
             neuropathic pain.&#xD;
&#xD;
          -  Head trauma associated altering somatosensory system or cognitive abilities and higher&#xD;
             functions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>vincent ROUALDES, MD</last_name>
    <phone>02 40 16 50 69</phone>
    <email>vincent.roulades@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>aur√©lien Van Langhenhove</last_name>
    <phone>02 40 16 51 73</phone>
    <email>aurelien.vanlanghenhove@chu-nantes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nantes Uh</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent ROUALDES, MD</last_name>
      <email>vincent.roualdes@chu-nantes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 8, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2019</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

